Utilization of FibroScan in clinical practice

Area of Science:

• Hepatology
• Medical Imaging
• Diagnostic Technologies

Background:

• Accurate liver fibrosis evaluation is crucial for patient management, especially to exclude cirrhosis.
• Liver biopsy, the traditional method, carries risks and limitations.
• Non-invasive tests are increasingly adopted for staging liver fibrosis.

Purpose of the Study:

• To review the performance characteristics of transient ultrasound elastography for liver fibrosis assessment.
• To provide practical guidance on incorporating elastography into clinical practice.
• To discuss elastography's utility across diverse liver diseases.

Main Methods:

• Literature review of studies evaluating transient ultrasound elastography.
• Analysis of performance metrics (sensitivity, specificity) for fibrosis staging.
• Synthesis of clinical practice guidelines and expert recommendations.

Main Results:

• Transient ultrasound elastography demonstrates significant accuracy in staging liver fibrosis.
• The technology is a viable alternative to liver biopsy for many liver conditions.
• Performance varies depending on the underlying liver disease etiology.

Conclusions:

• Transient ultrasound elastography is a valuable non-invasive tool for liver fibrosis evaluation.
• Its integration into clinical practice can improve patient care and diagnostic efficiency.
• Further research may refine its application in specific clinical scenarios.